The assessment of MMP-7 activity is considered to be clinically important for patients with IPF, chronic obstructive pulmonary disease (COPD), small cell lung cancer, adenocarcinoma, and squamous cell carcinoma [25,27,29,30,58,59]. Here, MMP7 is linked to small cell lung carcinoma.